Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.83 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xylitol SCHEMBL13080875 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Xylitol SCHEMBL4599492 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Xylitol SCHEMBL5306386 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Xylitol SCHEMBL8749454 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Xylitol SCHEMBL5273838 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Adonitol SCHEMBL20594035 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Xylitol SCHEMBL1924966 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Adonitol SCHEMBL22572531 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Xylitol SCHEMBL20594034 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Xylitol SCHEMBL16627357 | 1.00 | LMNA (0.83) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6075059-A | COMPRISING WATER, A LOCAL ANESTHETIC AGENT, AND A SUGAR ALCOHOL | THE OHIO STATE UNIVERSITY (US) | 2000-06-13 | — | — | US | claimed |
| CN-116261597-A | Production of Fuc-a1,2-Gal-R in the alpha-1, 3 glycosylated form | 因比奥斯公司 | 2023-06-13 | — | — | CN | disclosed |
| US-11059835-B2 | Synthesis of cephalosporin compounds | MERCK SHARP & DOHME CORP. (US) | 2021-07-13 | — | — | US | disclosed |
| US-20200385404-A1 | SYNTHESIS OF CEPHALOSPORIN COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2020-12-10 | — | — | US | disclosed |
| EP-3727652-A1 | SYNERGIZED ACETALS COMPOSITION AND METHOD FOR SCAVENGING SULFIDES AND MERCAPTANTS | Clariant International Ltd (CH) | 2020-10-28 | — | — | EP | disclosed |
| WO-2018182774-A1 | HERBICIDE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2018-10-04 | — | — | WO | disclosed |
| EP-2872110-A2 | COSMETIC COMPOSITION COMPRISING BENZYLSULFONYL-D-SER-HOMOPHE-(4-AMIDINO-BENZYLAMIDE) AND A POLYALCOHOL | DSM IP Assets B.V. (NL) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014009862-A2 | COSMETIC COMPOSITION COMPRISING BENZYLSULFONYL-D-SER-HOMOPHE-(4-AMIDINO-BENZYLAMIDE) AND A POLYALCOHOL | DSM IP ASSETS B.V. (NL) | 2014-01-16 | — | — | WO | disclosed |
| US-6075059-A | COMPRISING WATER, A LOCAL ANESTHETIC AGENT, AND A SUGAR ALCOHOL | THE OHIO STATE UNIVERSITY (US) | 2000-06-13 | — | — | US | disclosed |
| US-4371656-A | Metal substituted zeolites as stabilizers for halogen-containing resins | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 1983-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200385404-A1 | SYNTHESIS OF CEPHALOSPORIN COMPOUNDS | COASY, DDT, PEPD | LMNA 4633/4885L3MBTL1 4445/4885TDP1 4243/4885 |
| US-11059835-B2 | Synthesis of cephalosporin compounds | COASY, DDT, PEPD | LMNA 4633/4885L3MBTL1 4445/4885TDP1 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.